Condition
Respiration Failure
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06333379Completed
Aspergillosis Detection Via EBC-GM in Ventilated Patients
NCT02983565Not ApplicableCompletedPrimary
Intelligent Oxygen Therapy During Sleep
NCT02963142Completed
A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia
NCT02973243Completed
The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III
Showing all 4 trials